BioSpace News Archive

Gandeeva Therapeutics today announced the formation of its Scientific Advisory Board (SAB).

Avinger, Inc. today announced full commercial availability of its new Lightbox 3 imaging console designed to enhance the user experience and drive faster adoption at new hospital sites.

L-Nutra Inc., the world’s leading nutrition technology company pioneering the discovery, design, and commercialization of novel programs and therapeutics that impact both the body’s metabolism and cellular rejuvenation, today announced data from a first-of-its-kind study evaluating the impact of its Fasting Mimicking Technology (FMT) on metabolic risk factors in patients with prostate cancer (PC).

Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, announced the appointment of Ashok Marín, Esq., to the position of General Counsel, effective immediately.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that BREXAFEMME® (ibrexafungerp tablets) has achieved additional significant listings on national and regional formularies during the first quarter of 2022.

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, announced today that GIMOTI® (metoclopramide) nasal spray a novel treatment solution for the treatment of symptoms associated with diabetic gastroparesis (DGP), has been added to the Texas Medicaid Preferred Drug List (PDL), effective April 12, 2022.

CinCor Pharma, Inc. announced its participation in the Jefferies Biotech on the Bay Summit taking place April 26-27 in Miami, Florida.

IMPLICITY®, a global leader in remote patient monitoring and cardiac data management solutions, is showcasing its portfolio of remote cardiac monitoring solutions at the upcoming Heart Rhythm 2022 (HRS 2022) in San Francisco, California, hosted by the Heart Rhythm Society, between April 29th and May 1st, 2022.

Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data from its leading eye care portfolio at the 2022 American Society for Cataract and Refractive Surgery (ASCRS) Annual Meeting being held April 22 – 26 in Washington, D.C.

LogicMark, Inc. announces financial and operating results for the fourth quarter and full year ended December 31, 2022.